vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and CHIMERA INVESTMENT CORP (CIM). Click either name above to swap in a different company.

CHIMERA INVESTMENT CORP is the larger business by last-quarter revenue ($66.2M vs $38.9M, roughly 1.7× CODEXIS, INC.). CHIMERA INVESTMENT CORP runs the higher net margin — 42.8% vs 24.7%, a 18.1% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 0.5%). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 0.8%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Chimera Investment Corp is a US-based real estate investment trust (REIT) primarily investing in residential mortgage-backed securities, residential and commercial mortgage loans, and other real estate-related financial assets. It delivers sustainable risk-adjusted returns for shareholders via regular dividend distributions from its investment portfolio.

CDXS vs CIM — Head-to-Head

Bigger by revenue
CIM
CIM
1.7× larger
CIM
$66.2M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+80.8% gap
CDXS
81.3%
0.5%
CIM
Higher net margin
CIM
CIM
18.1% more per $
CIM
42.8%
24.7%
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
0.8%
CIM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
CIM
CIM
Revenue
$38.9M
$66.2M
Net Profit
$9.6M
$28.3M
Gross Margin
94.8%
Operating Margin
27.1%
42.6%
Net Margin
24.7%
42.8%
Revenue YoY
81.3%
0.5%
Net Profit YoY
192.5%
119.3%
EPS (diluted)
$0.13
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
CIM
CIM
Q4 25
$38.9M
$66.2M
Q3 25
$8.6M
$65.0M
Q2 25
$15.3M
$66.0M
Q1 25
$7.5M
$69.2M
Q4 24
$21.5M
$65.8M
Q3 24
$12.8M
$66.5M
Q2 24
$8.0M
$67.3M
Q1 24
$17.1M
$65.1M
Net Profit
CDXS
CDXS
CIM
CIM
Q4 25
$9.6M
$28.3M
Q3 25
$-19.6M
$-580.0K
Q2 25
$-13.3M
$35.5M
Q1 25
$-20.7M
$167.3M
Q4 24
$-10.4M
$-146.5M
Q3 24
$-20.6M
$136.5M
Q2 24
$-22.8M
$56.7M
Q1 24
$-11.5M
$129.5M
Gross Margin
CDXS
CDXS
CIM
CIM
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
CIM
CIM
Q4 25
27.1%
42.6%
Q3 25
-220.3%
-0.5%
Q2 25
-83.9%
54.3%
Q1 25
-271.6%
Q4 24
-34.2%
-222.6%
Q3 24
-129.0%
Q2 24
-284.9%
84.2%
Q1 24
-69.6%
Net Margin
CDXS
CDXS
CIM
CIM
Q4 25
24.7%
42.8%
Q3 25
-228.1%
-0.9%
Q2 25
-86.6%
53.7%
Q1 25
-274.3%
241.7%
Q4 24
-48.4%
-222.6%
Q3 24
-160.8%
205.4%
Q2 24
-285.2%
84.2%
Q1 24
-67.4%
198.8%
EPS (diluted)
CDXS
CDXS
CIM
CIM
Q4 25
$0.13
$0.05
Q3 25
$-0.22
$-0.27
Q2 25
$-0.16
$0.17
Q1 25
$-0.25
$1.77
Q4 24
$-0.12
$-2.06
Q3 24
$-0.29
$1.39
Q2 24
$-0.32
$0.41
Q1 24
$-0.16
$1.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
CIM
CIM
Cash + ST InvestmentsLiquidity on hand
$78.2M
$278.6M
Total DebtLower is stronger
$40.1M
$251.5M
Stockholders' EquityBook value
$50.5M
$2.6B
Total Assets
$147.8M
$15.8B
Debt / EquityLower = less leverage
0.79×
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
CIM
CIM
Q4 25
$78.2M
$278.6M
Q3 25
$58.7M
$491.5M
Q2 25
$66.3M
$250.2M
Q1 25
$59.8M
$253.3M
Q4 24
$73.5M
$84.0M
Q3 24
$90.3M
$97.3M
Q2 24
$73.2M
$162.3M
Q1 24
$85.5M
$169.0M
Total Debt
CDXS
CDXS
CIM
CIM
Q4 25
$40.1M
$251.5M
Q3 25
$39.7M
$251.0M
Q2 25
$39.4M
$135.2M
Q1 25
$29.2M
$134.9M
Q4 24
$28.9M
$134.6M
Q3 24
$28.6M
$134.4M
Q2 24
$28.4M
$62.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
CIM
CIM
Q4 25
$50.5M
$2.6B
Q3 25
$38.5M
$2.6B
Q2 25
$55.6M
$2.6B
Q1 25
$49.6M
$2.6B
Q4 24
$66.9M
$2.5B
Q3 24
$73.4M
$2.7B
Q2 24
$61.4M
$2.6B
Q1 24
$79.3M
$2.6B
Total Assets
CDXS
CDXS
CIM
CIM
Q4 25
$147.8M
$15.8B
Q3 25
$124.0M
$15.1B
Q2 25
$138.2M
$14.9B
Q1 25
$128.9M
$13.2B
Q4 24
$149.0M
$13.1B
Q3 24
$148.2M
$13.7B
Q2 24
$132.0M
$13.1B
Q1 24
$149.6M
$12.5B
Debt / Equity
CDXS
CDXS
CIM
CIM
Q4 25
0.79×
0.10×
Q3 25
1.03×
0.10×
Q2 25
0.71×
0.05×
Q1 25
0.59×
0.05×
Q4 24
0.43×
0.05×
Q3 24
0.39×
0.05×
Q2 24
0.46×
0.02×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
CIM
CIM
Operating Cash FlowLast quarter
$20.1M
$-248.9M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
2.09×
-8.78×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
CIM
CIM
Q4 25
$20.1M
$-248.9M
Q3 25
$-7.7M
$-137.5M
Q2 25
$-18.0M
$-7.4M
Q1 25
$-13.8M
$48.8M
Q4 24
$-16.5M
$205.7M
Q3 24
$-13.0M
$41.4M
Q2 24
$-12.2M
$69.0M
Q1 24
$-7.8M
$57.3M
Free Cash Flow
CDXS
CDXS
CIM
CIM
Q4 25
$19.6M
Q3 25
$-7.9M
Q2 25
$-20.5M
Q1 25
$-15.1M
Q4 24
$-18.2M
Q3 24
$-14.0M
Q2 24
$-12.6M
Q1 24
$-8.9M
FCF Margin
CDXS
CDXS
CIM
CIM
Q4 25
50.3%
Q3 25
-91.7%
Q2 25
-133.6%
Q1 25
-199.6%
Q4 24
-85.0%
Q3 24
-109.0%
Q2 24
-157.5%
Q1 24
-52.2%
Capex Intensity
CDXS
CDXS
CIM
CIM
Q4 25
1.3%
Q3 25
2.1%
Q2 25
16.4%
Q1 25
16.7%
Q4 24
8.3%
Q3 24
7.8%
Q2 24
5.0%
Q1 24
6.6%
Cash Conversion
CDXS
CDXS
CIM
CIM
Q4 25
2.09×
-8.78×
Q3 25
Q2 25
-0.21×
Q1 25
0.29×
Q4 24
Q3 24
0.30×
Q2 24
1.22×
Q1 24
0.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons